Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
932.4500 6.80 (0.73%)
NSE Feb 06, 2026 15:31 PM
Volume: 101.8K
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
932.45
0.73%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences Ltd. is trading above its 100 day SMA of 913.8
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - February 6, 2026
The Baseline | 06 Feb 2026, 04:20PM
Market closes higher as RBI raises FY26 GDP growth forecast to 7.4%
Trendlyne Marketwatch | 06 Feb 2026, 04:08PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021